Biomarker Technologies (BMKGENE) has been actively engaged in innovation and developing high-throughput sequencing technologies and bioinformatics for over 13 years.

We have brought in the most cutting-edge high-throughput sequencing platforms, including Illumina, Nanopore, PacBio, 10X Genomics, and high-performance computing platforms.

We offer services covering genomics, transcriptomics, single-cell omics, microbial genomics and epigenetics.

Our company has a passionate and highly-skilled R&D team with over 500 members, over 60 nation patents of inventions and over 200 software copyrights on bioinformatics analyses.

With a robust ability in tackling scientific and technical issues, we have contributed to thousands of high-impact publications.